OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BLCO$16.0057

BLCO.K

Medical Equipment, Supplies & DistributionVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.79, indicating a moderate level of leverage. The liquidity position is marked by a current ratio of 1.55, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -280 million USD, which may indicate a need for external financing or operational adjustments. Profitability metrics show a return on equity of -5.58% and a return on assets of -2.57%, both of which are below the industry median, indicating that the company is underperforming in terms of generating returns for its shareholders and assets. The operating margin is 2.1%, which is also below the industry median, suggesting that the company is not as efficient in converting revenue into operating profit as its peers. The company's revenue is concentrated in a single segment, with no disclosed geographic diversification, which may expose the company to higher risk if the segment or region experiences a downturn. The company's growth trajectory is uncertain, with no significant revenue growth reported in the latest financial period. The company faces a risk of dilution, although the risk is currently assessed as low. The company's liquidity risk is medium, as indicated by the risk assessment, and the company has a negative net cash position after subtracting total debt. Recent events, such as the company's net loss of 360 million USD, may impact investor sentiment and the company's ability to attract capital.

30-day price · BLCO-1.00 (-6.0%)
Low$15.26High$17.12Close$15.59As of28 May, 00:00 UTC
Profile
CompanyBLCO.K
TickerBLCO.K
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. BLCO.K operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Classification. The company is classified under the Healthcare Services & Equipment business sector and the Medical Equipment, Supplies & Distribution industry with a confidence level of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 0.79, indicating a moderate level of leverage. The liquidity position is marked by a current ratio of 1.55, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -280 million USD, which may indicate a need for external financing or operational adjustments. Profitability metrics show a return on equity of -5.58% and a return on assets of -2.57%, both of which are below the industry median, indicating that the company is underperforming in terms of generating returns for its shareholders and assets. The operating margin is 2.1%, which is also below the industry median, suggesting that the company is not as efficient in converting revenue into operating profit as its peers. The company's revenue is concentrated in a single segment, with no disclosed geographic diversification, which may expose the company to higher risk if the segment or region experiences a downturn. The company's growth trajectory is uncertain, with no significant revenue growth reported in the latest financial period. The company faces a risk of dilution, although the risk is currently assessed as low. The company's liquidity risk is medium, as indicated by the risk assessment, and the company has a negative net cash position after subtracting total debt. Recent events, such as the company's net loss of 360 million USD, may impact investor sentiment and the company's ability to attract capital.
Key takeaways
  • The company has a moderate level of leverage with a debt-to-equity ratio of 0.79.
  • The company's profitability metrics are below the industry median, indicating underperformance.
  • The company's revenue is concentrated in a single segment, which may increase risk.
  • The company's liquidity position is medium, with a current ratio of 1.55.
  • The company has a negative free cash flow, which may require external financing.
  • The company's risk of dilution is currently assessed as low.
  • # RATIONALES
  • margin_outlook_rationale: The company's operating margin is below the industry median, indicating potential inefficiencies in converting revenue into profit.
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$5.10B
Gross profit$3.05B
Operating income$107.0M
Net income-$360.0M
R&D
SG&A
D&A
SBC
Operating cash flow$283.0M
CapEx-$349.0M
Free cash flow-$280.0M
Total assets$14.02B
Total liabilities$7.57B
Total equity$6.45B
Cash & equivalents$383.0M
Long-term debt$5.08B
Valuation
Market price$16.00
Market cap$5.70B
Enterprise value$10.40B
P/E
Reported non-GAAP P/E
EV/Revenue2.0
EV/Op income97.2
EV/OCF36.8
P/B0.9
P/Tangible book0.9
Tangible book$6.45B
Net cash-$4.70B
Current ratio1.6
Debt/Equity0.8
ROA-2.6%
ROE-5.6%
Cash conversion-79.0%
CapEx/Revenue-6.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricBLCOActivity
Op margin2.1%3.9% medp25 -31.3% · p75 14.4%below median
Net margin-7.1%2.4% medp25 -30.5% · p75 11.1%below median
Gross margin59.8%46.7% medp25 28.2% · p75 63.1%above median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-6.8%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity79.0%17.9% medp25 2.7% · p75 52.2%top quartile
Observations
IR observations
Mean price target18.25 USD
Median price target18.00 USD
High price target21.00 USD
Low price target16.00 USD
Mean recommendation2.69 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count3.00
Hold count8.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate0.78 USD
Last actual EPS0.51 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 20:05 UTC#ae637212
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 12:41 UTCJob: 00e7efca